How Schwab Network’s view on $VEEV changed

Channel profile →This channel has 3 credited speakers: Morgan Stanley, Truist, UBS1 entry
2026-08-31Bullish
“Bodner: Expect "Choppy" September, NVDA Set Stage for End of 2026 Rally”
VEEV is a strong buy as a stealth tech company in healthcare with phenomenal sales and earnings growth.

Some of the companies that I really like in healthcare are also kind of stealthy tech companies like Veeva healthcare systems. They manage sort of cloud data management for doctors, patients, computer communication protocol, etc. And they've had just phenomenal sales and earnings growth.

So yeah, I think they're great opportunities to sort of play both sides of the fence in healthcare as we move forward.